Dave Messina

At Pioneer Fund he has led the Health/Bio practice since 2019, serves as General Partner of the Future of Health Fund, and has personally led over 100 deals in early-stage health and biotech. Dave combined deep technical expertise (genome sequencing, standards, bioinformatics tooling) with operator experience founding Cofactor Genomics (a Y Combinator company) and leading its operations, regulatory strategy, and commercialization securing national Medicare reimbursement for its diagnostic technology. davemessina+2

Clinical & translational focus: at Cofactor he concentrated on converting RNA sequencing signals into multidimensional, clinically-actionable biomarkers (immune profiling / predictive immune models), working through CAP/CAP-like validation and payer/regulatory pathways — practical domain experience that complements his current investing in translational bio + health startups. reportablenews+2

Open‑source and standards‑minded scientist: across his PhD and early career Messina authored tools and formats (DASher, SeqXML/OrthoXML) and contributed as a core developer to BioPerl — signaling strengths in building reusable software, data-exchange standards, and reproducible analysis infrastructure for genomics; earlier in his career he also contributed to large-scale sequencing efforts including the Human Genome Project. davemessina+2

Teacher and community contributor: Messina has taught and assisted in computational biology programming courses (e.g., Cold Spring Harbor Programming for Biologists), contributing to capacity-building in the bioinformatics community while publishing peer-reviewed methods and tools. davemessina+1